BRUGUIESULFUROL

ID: ALA2419097

Max Phase: Preclinical

Molecular Formula: C3H6O3S2

Molecular Weight: 154.21

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=S1(=O)C[C@H](O)CS1

Standard InChI:  InChI=1S/C3H6O3S2/c4-3-1-7-8(5,6)2-3/h3-4H,1-2H2/t3-/m1/s1

Standard InChI Key:  NGIJTYOKLKCHNE-GSVOUGTGSA-N

Associated Targets(Human)

Receptor-type tyrosine-protein phosphatase F (LAR) 718 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-tyrosine phosphatase 2C 2297 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-tyrosine phosphatase 1C 687 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

T-cell protein-tyrosine phosphatase 1317 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein-tyrosine phosphatase 1B 8528 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 154.21Molecular Weight (Monoisotopic): 153.9758AlogP: -0.58#Rotatable Bonds: 0
Polar Surface Area: 54.37Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.83CX Basic pKa: CX LogP: -0.97CX LogD: -0.97
Aromatic Rings: 0Heavy Atoms: 8QED Weighted: 0.47Np Likeness Score: -0.16

References

1. Chen J, Jiang CS, Ma WQ, Gao LX, Gong JX, Li JY, Li J, Guo YW..  (2013)  The first synthesis of natural disulfide bruguiesulfurol and biological evaluation of its derivatives as a novel scaffold for PTP1B inhibitors.,  23  (18): [PMID:23942421] [10.1016/j.bmcl.2013.07.039]

Source